J CARDIOVASC PHARM T 润色咨询

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

出版年份:1996 年文章数:642 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:2.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=5c5a3536, cover=https://img.medsci.cn/images/journal/cover/2021/RoT_202109271315321810.jpg, fullname=JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, abbr=J CARDIOVASC PHARM T, pyear=1996, frequence=Quarterly, articleNumbers=642, citedSelf2015=2.8, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1074-2484, greenSci=https://www.greensci.net/search?kw=1074-2484, scijournal=https://www.scijournal.org/impact-factor-of-J-CARDIOVASC-PHARM-T.shtml, medsciHotlightString=null, medsciHotlightRealtime=5.945, medsciHotlight=5.166, medsciHotlight5year=6.89968, citescore=4.3, hIndex=50, impactFactor=2.6, orgnization=SAGE Publications Ltd, orgnizationUrl=http://www.sagepub.co.uk, country=United States, countryCn=美国, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 4 区, website=http://cpt.sagepub.com/, websiteHits=10142, guideForAuthor=https://us.sagepub.com/en-us/nam/journal-of-cardiovascular-pharmacology-and-therapeutics/journal201790#submission-guidelines, guideForAuthorHits=634, submitWebsite=https://mc.manuscriptcentral.com/jcpat, submitWebsiteHits=3455, content=<i style="box-sizing: border-box; color: rgb(51, 51, 51); font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 20px;">Journal of Cardiovascular Pharmacology and Therapeutics</i><span style="color: rgb(51, 51, 51); font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 20px;"> is a peer-reviewed journal that publishes original basic human studies, original animal studies, and original bench research with potential clinical application to cardiovascular pharmacology and therapeutics. The focus of the experimental studies is translational research. The journal also publishes review articles on basic research, clinical research, editorials, commentaries, points of view, and controversies. Selected journal supplements will also be published. Future focus will include cardioprotective therapies, stem cell therapy, regenerative cardiology, therapies for preventive cardiology (risk factor management), and antiarrhythmic therapies.  Selected journal supplements will also be published.</span><div><span style="color: rgb(51, 51, 51); font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 20px;"><br></span></div><div><p style="box-sizing: border-box; margin-top: 0px; margin-bottom: 14px; color: rgb(51, 51, 51); font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 20px;">Every informative issue of <em style="box-sizing: border-box;">Journal of Cardiovascular Pharmacology and Therapeutics (JCPT)</em><strong style="box-sizing: border-box;"> </strong>offers cardiologists, clinical pharmacologists and researchers involved in disease relevant clinical and experimental investigations of newer cardiovascular drugs and other therapeutic options. Four times a year, <em style="box-sizing: border-box;">JCPT </em>examines and analyzes arenas such as:</p><ul style="box-sizing: border-box; margin: 14px 0px; padding-left: 40px; color: rgb(51, 51, 51); font-family: Arial, Helvetica, sans-serif; font-size: 14px; line-height: 20px;"><ul type="disc" style="box-sizing: border-box; margin: 14px 0px; padding-left: 40px;"><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Agents that Reduce Myocardial Infarct Size</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Agents that Reduce Myocardial Remodeling</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Angiotensin Converting Enzyme Inhibitors</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Antihypertensive Therapy</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Arrhythmias</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Atrial Fibrillation</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Beta-Blocker Therapies</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Cardioembolic Stroke</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Cardiomyopathy</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Cardioprotective Agents</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Cardiopulmonary Resuscitation</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Cardiovascular Combination Therapies</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Chronic Angina</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Chronic Cardiac Ischemia</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Congestive Heart Failure</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Coronary Artery Disease</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Coronary Revascularization</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Heparin Therapies</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Hypertension</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Hypotension</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Implantable Devices</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Ischemic Heart Disease</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Myocardial Infarction</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Percutaneous Coronary Interventions</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Peripheral Arterial Disease</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Preconditioning/Postconditioning</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Regenerative Cardiology</li><li style="box-sizing: border-box; text-align: justify; line-height: 16.8px; background-image: initial; background-attachment: initial; background-size: initial; background-origin: initial; background-clip: initial; background-position: initial; background-repeat: initial;">Stem Cell Therapy</li></ul></ul></div>, totalCites=1671, brief=J CARDIOVASC PHARM T杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=心血管系统" >心血管系统</a></strong>”子行业的偏低级别杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=5c5a3536'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=266, tagName=心血管, createdHits=19), ImpactFactorTagDto(id=1113, tagName=药物治疗, createdHits=2), ImpactFactorTagDto(id=3516, tagName=电生理, createdHits=1), ImpactFactorTagDto(id=57860, tagName=瓣膜疾病, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.47), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.75), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.22), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=11.161), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=5.961), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=4.946), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=5.452), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=5.945)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Cardiology and Cardiovascular Medicine , rank=84/322), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=87/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=135/300)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1074-2484[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS[ta], article_number=27, article_number_cn=1, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
J CARDIOVASC PHARM T/JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
ISSN
1074-2484
影响指数话题
预警等级
MedSci期刊指数
5.945 (MedSci实时期刊指数) | 6.89968 (5年期刊指数)
CiteScore值
4.3
h-index
50
h5-median
暂无数据
出版社/管理机构
杂志由 SAGE Publications Ltd 出版或管理
出版国家/地区
United States 美国
出版周期
Quarterly
出版年份
1996
是否OA
被收录情况
Science Citation Index Expanded|Current Contents - Clinical Medicine|BIOSIS Previews
JCR分区
暂无数据
中科院分区
大类:医学 3区
小类:医学 4 区